Institut Cancerologie De L'ouest

This study aimed to test whether adding a targeted drug (bemarituzumab) to standard chemotherapy (FLOT) could improve outcomes for people with a certain type of stomach or gastroesophageal junction cancer that overexpresses FGFR2b. The treatment was given before and after surgery…

This study tests whether adding the drug durvalumab to targeted radiation therapy helps control prostate cancer that has come back in a few spots (up to 5). About 96 men with hormone-sensitive prostate cancer will receive either radiation alone or radiation plus durvalumab for 12…

This study looks at a way to help women under 40 with breast cancer keep their ability to have children after chemotherapy. Before starting chemo, participants receive hormone shots and tamoxifen to stimulate their ovaries, then eggs or embryos are frozen. The goal is to see if t…

This study looks at a breast reconstruction method that uses a smaller piece of back muscle to rebuild the breast after mastectomy. The goal is to see if this less invasive approach causes less shoulder pain and stiffness while still giving good cosmetic results. Researchers will…

This study looks at pregnancy and fertility in women who had breast cancer. Researchers will collect information from 22,000 patients aged 18 to 50 at diagnosis to see how many get pregnant, whether they used fertility preservation, and the health of their babies. The goal is to …